Physician profile
John C Wander
NPI 1326132192
$1,383.33
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $110 · 2021: $191 · 2022: $121 · 2023: $123 · 2024: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $297.49 | 2019-2022 | |
| Amgen INC. | $212.03 | 2019-2021 | |
| Inari Medical, INC. | $145.08 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals Lp | $133.39 | 2019-2023 | Breztri |
| Abbvie INC. | $102.75 | 2019-2021 | |
| Pfizer INC. | $85.76 | 2019-2021 | |
| Novo Nordisk INC | $69.63 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.74 | 2019-2021 | |
| Amarin Pharma, INC. | $41.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.92 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $29.53 | 2019-2021 | |
| Abbott Laboratories | $28.72 | 2019-2020 | |
| Allergan, INC. | $24.76 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $23.00 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $22.57 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $19.04 | 2021 | |
| Bausch Health US, LLC | $14.55 | 2019 | |
| Nevro Corp. | $13.48 | 2019 | |
| Lilly USA, LLC | $11.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.